Learn More
Cayman Chemical Monascus nkaflavIn 10mg

Supplier: Cayman Chemical 3954610 MG
A microbial metabolite with diverse biological activities; induces cytotoxicity in HepG2 and A549 cancer cells (IC50 = ~15 UG/ml for both); induces cell cycle arrest at the G0 phase in HepG2 cells at 15 UG/ml; reduces NO production in LPS-stimulated RAW 264.7 macrophages at 5, 10, and 15 UG/ml; increases lipolysis activity in IBMX-, dexamethasone-, and insulin-matured 3T3-L1 adipocytes at 10 µM; reduces blood glucose and serum insulin levels in mice fed a high-fat diet at 5 mg/kg per day
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.